Patient-derived tumor organoid and fibroblast assembloid models for interrogation of the tumor microenvironment in esophageal adenocarcinoma

Benjamin P. Sharpe(University of Southampton), Tim Underwood(Southampton General Hospital)
Cell Reports Methods
November 27, 2024
10.1016/j.crmeth.2024.100909
Cited by 10

Related Papers

Cancer‐associated fibroblasts predict poor outcome and promote periostin‐dependent invasion in oesophageal adenocarcinoma
|The Journal of Pathology|2014|182
Aspirin as an adjuvant treatment for cancer: feasibility results from the Add-Aspirin randomised trial
|˜The œLancet. Gastroenterology & hepatology|2019|64
Immune activation by DNA damage predicts response to chemotherapy and survival in oesophageal adenocarcinoma
|Gut|2019|27
Phosphodiesterase type 5 inhibitors enhance chemotherapy in preclinical models of esophageal adenocarcinoma by targeting cancer-associated fibroblasts
|Cell Reports Medicine|2022|24
Modulation of the tumour promoting functions of cancer associated fibroblasts by phosphodiesterase type 5 inhibition increases the efficacy of chemotherapy in human preclinical models of esophageal adenocarcinoma
|bioRxiv (Cold Spring Harbor Laboratory)|2020|2